Literature DB >> 8971664

Mood disorder and chronic hypercalcemia.

R E White1, A Pickering, G S Spathis.   

Abstract

Fifty-five patients with chronic hypercalcemia were compared with test norms, and two comparison groups of orthopedic patients and hypertensive patients on objective and subjective tests of mood. Sixteen percent of the hypercalcemic patients were found to score over the cut-off point for anxiety on the anxiety subsection of the Hospital Anxiety and Depression Scale, and 16% were diagnosed as suffering from depression on the Paykel Clinical Interview for Depression. There were, however, no significant differences between the comparison groups and those with hypercalcemia on the scales used. There has been debate about the management of individuals with hypercalcemia. This study supports a conservative rather than a surgical approach as far as psychological symptoms are concerned.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971664     DOI: 10.1016/s0022-3999(96)00132-8

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

1.  Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism.

Authors:  Tevfik Fikret Cermik; Meryem Kaya; Betül Uğur-Altun; Deniz Bedel; Sakir Berkarda; Omer N Yiğitbaşi
Journal:  Neuroradiology       Date:  2007-01-05       Impact factor: 2.804

2.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

3.  Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.

Authors:  Theresia Weber; Monika Keller; Isabella Hense; Alexander Pietsch; Ulf Hinz; Tobias Schilling; Peter Nawroth; Ernst Klar; Markus W Büchler
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.